tiprankstipranks
InspireMD (NSPR)
NASDAQ:NSPR
Holding NSPR?
Track your performance easily

InspireMD (NSPR) Technical Analysis

683 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
InspireMD’s (NSPR) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting InspireMD is a Sell.
InspireMD’s (NSPR) 20-Day exponential moving average is 2.50, while InspireMD’s (NSPR) share price is $2.64, making it a Buy.
InspireMD’s (NSPR) 50-Day exponential moving average is 2.55, while InspireMD’s (NSPR) share price is $2.64, making it a Buy.

InspireMD (NSPR) Pivot Points

Nov 21, 2024, 06:57 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.42
2.46
2.52
2.56
2.62
2.66
2.72
Fibonacci
2.46
2.49
2.52
2.56
2.59
2.62
2.66
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

InspireMD (NSPR) Moving Averages

Nov 21, 2024, 06:57 PM
Period
Simple
Exponential
MA5
2.55Buy
2.54Buy
MA10
2.47Buy
2.51Buy
MA20
2.47Buy
2.50Buy
MA50
2.57Sell
2.55Buy
MA100
2.65Sell
2.59Sell
MA200
2.54Buy
2.56Buy
InspireMD’s (NSPR) 10-Day exponential moving average is 2.51, while InspireMD’s (NSPR) share price is $2.64, making it a Buy.
InspireMD’s (NSPR) 100-Day exponential moving average is 2.59, while InspireMD’s (NSPR) share price is $2.64, making it a Sell.
InspireMD’s (NSPR) stock price is $2.64 and InspireMD’s (NSPR) 50-day simple moving average is 2.57, creating a Sell signal.
InspireMD’s (NSPR) stock price is $2.64 and InspireMD’s (NSPR) 100-day simple moving average is 2.65, creating a Sell signal.
InspireMD’s (NSPR) stock price is $2.64 and InspireMD’s (NSPR) 200-day simple moving average is 2.54, creating a Buy signal.

InspireMD (NSPR) Technical Indicators

Nov 21, 2024, 06:57 PM
Name
Value
Implied Action
RSI (14)
54.58
Neutral
STOCH (9,6)
50.34
Neutral
STOCHRSI (14)
50.34
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
29.82
Neutral
Williams %R
-48.98
Buy
CCI (14)
102.43
Sell
ATR (14)
0.19
-
Ultimate Oscillator
52.51
Neutral
ROC
3.63
Buy
InspireMD’s (NSPR) Relative Strength Index (RSI) is 54.58, creating a Neutral signal.
InspireMD’s (NSPR) Trend Strength Indicator (ADX) is 29.82, creating a Neutral signal.
InspireMD’s (NSPR) Commodity Channel Index (CCI) is 102.43, creating a Sell signal.
InspireMD’s (NSPR) Price Rate of Change (ROC) is 3.63, creating a Buy signal.

FAQ

Is NSPR a Buy, Hold, or Sell?
Based on NSPR’s technical indicators, NSPR is a Buy.
    What is NSPR’s RSI (14)?
    NSPR’s RSI (14) is 54.58, which suggests NSPR is a Neutral.
      What is NSPR’s MACD?
      NSPR’s MACD is >-0.01, which suggests NSPR is a Sell.
        What is NSPR’s 5-day moving average?
        NSPR’s 5-day moving average is 2.55, which suggests NSPR is a Buy.
          What is NSPR’s 20-day moving average?
          NSPR 20-day moving average is 2.47, which suggests NSPR is a Buy.
            What is NSPR’s 50-day moving average?
            NSPR’s 50-day moving average is 2.57, which suggests NSPR is a Sell.
              What is NSPR’s 200-day moving average?
              NSPR’s 200-day moving average is 2.54, which suggests NSPR is a Buy.
                What is NSPR’s Williams % R (14)?
                NSPR’s Williams % R (14) is -48.98, which suggests NSPR is a Buy.
                  What is NSPR’s CCI (14)?
                  NSPR’s CCI (14) is 102.43, which suggests NSPR is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis